Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Neoplasms of the CNS

Free Subscription 10.06.2024 1 Acta Neuropathol 2 AJNR Am J Neuroradiol 1 BMC Cancer 1 Br J Cancer 1 Childs Nerv Syst 3 Clin Cancer Res 2 J Clin Oncol 12 J Neurooncol 1 J Neuropathol Exp Neurol 5 J Neurosurg 9 Neuro Oncol 1 Neurology 1 Neuroradiology 3 Neurosurgery

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. OKONECHNIKOV K, Schrimpf D, Koster J, Sievers P, et al
   Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations.
   Acta Neuropathol. 2024;147:95.
   PubMed         Abstract available
   
   

   
   AJNR Am J Neuroradiol

2. PATEL SH, Lopes MB, Williams ES
   A Note of Caution Regarding Single-Arm 1p or 19q Deletion in IDH-Mutant Gliomas.
   AJNR Am J Neuroradiol. 2024 Jun 6. doi: 10.3174/ajnr.A8201.
   PubMed        
   
   
3. SONI N, Ora M, Bathla G, Szekeres D, et al
   Meningioma: Molecular Updates from the 2021 WHO Classification of CNS Tumors and Imaging Correlates.
   AJNR Am J Neuroradiol. 2024 Jun 6:ajnr.A8368. doi: 10.3174/ajnr.A8368.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. LIU ZY, Tang F, Wang J, Yang JZ, et al
   Serum beta2-microglobulin acts as a biomarker for severity and prognosis in glioma patients: a preliminary clinical study.
   BMC Cancer. 2024;24:692.
   PubMed         Abstract available
   
   

   
   Br J Cancer

5. QI L, Du Y, Huang Y, Kogiso M, et al
   CD57 defines a novel cancer stem cell that drive invasion of diffuse pediatric-type high grade gliomas.
   Br J Cancer. 2024 Jun 4. doi: 10.1038/s41416-024-02724.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

6. ODA Y, Amano K, Chiba K, Aihara Y, et al
   Pediatric craniopharyngioma with significantly increased intraoperative visual evoked potential amplitude and postoperative visual acuity improvement: a case report.
   Childs Nerv Syst. 2024 Jun 6. doi: 10.1007/s00381-024-06477.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

7. GAO M, Liu Z, Zang H, Wu X, et al
   A Histopathologic Correlation Study Evaluating Glymphatic Function in Brain Tumors by Multi-Parametric MRI.
   Clin Cancer Res. 2024 Jun 7. doi: 10.1158/1078-0432.CCR-24-0150.
   PubMed         Abstract available
   
   
8. AHLUWALIA MS, Ozair A, Drappatz J, Ye X, et al
   Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT.
   Clin Cancer Res. 2024 Jun 5. doi: 10.1158/1078-0432.CCR-23-4098.
   PubMed         Abstract available
   
   
9. PARK YW, Choi KS, Foltyn-Dumitru M, Brugnara G, et al
   Incorporating Supramaximal Resection into Survival Stratification of IDH-Wildtype Glioblastoma: A Refined Multi-institutional Recursive Partitioning Analysis.
   Clin Cancer Res. 2024 Jun 3. doi: 10.1158/1078-0432.CCR-23-3845.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

10. YU Y, Miao E, Pike LRG
    Improved CNS Control With the Addition of Chemotherapy to Osimertinib: A Devil's Bargain?
    J Clin Oncol. 2024;42:2107-2108.
    PubMed        
    
    
11. KOTECHA R, Schiff D, Chakravarti A, Fleming JL, et al
    Multidisciplinary Management of Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary Molecularly Defined Era.
    J Clin Oncol. 2024 Jun 4:JCO2302195. doi: 10.1200/JCO.23.02195.
    PubMed         Abstract available
    
    

    
    J Neurooncol

12. ZINSZ A, Ahrari S, Becker J, Mortada A, et al
    Amino-acid PET as a prognostic tool after post Stupp protocol temozolomide therapy in high-grade glioma patients.
    J Neurooncol. 2024 Jun 6. doi: 10.1007/s11060-024-04722.
    PubMed         Abstract available
    
    
13. TOYODA M, Shibahara I, Shigeeda R, Fujitani K, et al
    Clinical and molecular features of patients with IDH1 wild-type primary glioblastoma presenting unexpected short-term survival after gross total resection.
    J Neurooncol. 2024 Jun 5. doi: 10.1007/s11060-024-04687.
    PubMed         Abstract available
    
    
14. KUTUK T, Zhang Y, Akdemir EY, Yarlagadda S, et al
    Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis.
    J Neurooncol. 2024 Jun 5. doi: 10.1007/s11060-024-04706.
    PubMed         Abstract available
    
    
15. HOCKING MC, Schultz RT, Yerys BE, Minturn JE, et al
    White matter connectivity and social functioning in survivors of pediatric brain tumor.
    J Neurooncol. 2024 Jun 5. doi: 10.1007/s11060-024-04724.
    PubMed         Abstract available
    
    
16. PICART T, Hervey-Jumper S
    Central nervous system regulation of diffuse glioma growth and invasion: from single unit physiology to circuit remodeling.
    J Neurooncol. 2024 Jun 4. doi: 10.1007/s11060-024-04719.
    PubMed         Abstract available
    
    
17. BRAY DP, Stubbs NM, Chow J, Jahangiri A, et al
    Frailty in patients with IDH-mutant gliomas: experience from a high-volume tumor center.
    J Neurooncol. 2024 Jun 4. doi: 10.1007/s11060-024-04685.
    PubMed         Abstract available
    
    
18. BELLOMO J, Zeitlberger AM, Padevit L, Stumpo V, et al
    Role of microsurgical tumor burden reduction in patients with breast cancer brain metastases considering molecular subtypes: a two-center volumetric survival analysis.
    J Neurooncol. 2024 Jun 3. doi: 10.1007/s11060-024-04728.
    PubMed         Abstract available
    
    
19. CAPATINA C, Hanzu FA, Hinojosa-Amaya JM, Fleseriu M, et al
    Medical treatment of functional pituitary adenomas, trials and tribulations.
    J Neurooncol. 2024;168:197-213.
    PubMed         Abstract available
    
    
20. LAWSON MCLEAN AC, Lawson McLean A, Ernst T, Forster MT, et al
    Benchmarking palliative care practices in neurooncology: a german perspective.
    J Neurooncol. 2024;168:333-343.
    PubMed         Abstract available
    
    
21. BIELAMOWICZ KJ, Littrell MB, Albert GW, Parker LS, et al
    Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse.
    J Neurooncol. 2024;168:367-373.
    PubMed         Abstract available
    
    
22. YAMAMURA T, Tamura K, Kobayashi D, Inaji M, et al
    Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of (11)C-methionine in IDH-mutant astrocytoma.
    J Neurooncol. 2024;168:355-365.
    PubMed         Abstract available
    
    
23. DUAN L, He Y, Guo W, Du Y, et al
    Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma.
    J Neurooncol. 2024;168:283-298.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

24. LORETO PALACIO P, Pan X, Jones D, Otero JJ, et al
    Exploring a distinct FGFR2::DLG5 rearrangement in a low-grade neuroepithelial tumor: A case report and mini-review of protein fusions in brain tumors.
    J Neuropathol Exp Neurol. 2024 Jun 4:nlae040. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Neurosurg

25. FOO JQX, Zheng Y
    Letter to the Editor. 5-ALA fluorescence-guided surgery as standard of care in the resection of GBM.
    J Neurosurg. 2024;140:1816-1817.
    PubMed        
    
    
26. DELLA PEPA GM, Fraschetti F, Domenico MD, Valz Gris A, et al
    Predictive value of intraoperative vagus nerve corticobulbar motor evoked potentials to assess the risk of dysphagia in fourth ventricle surgery.
    J Neurosurg. 2023;140:1540-1548.
    PubMed         Abstract available
    
    
27. MCCLURE JJ, Chatrath A, Robison TR, Jane JA, et al
    Conditioned recurrence-free survival following gross-total resection of nonfunctioning pituitary adenoma: a single-surgeon, single-center retrospective study.
    J Neurosurg. 2023;140:1614-1619.
    PubMed         Abstract available
    
    
28. WANG W, He H, Zheng L, Zeng S, et al
    Enhancing brain entry and therapeutic activity of chimeric antigen receptor T cells with intra-arterial NEO100 in a mouse model of CNS lymphoma.
    J Neurosurg. 2023;140:1549-1557.
    PubMed         Abstract available
    
    
29. ROFES A, D'Agata F, Guerrini F, Spena G, et al
    Speech and lexico-semantic errors during direct cortical stimulation mapping of the language-dominant hemisphere: effects of object and action naming.
    J Neurosurg. 2024;140:1641-1659.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

30. LANG F, Cornwell JA, Kaur K, Elmogazy O, et al
    Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents.
    Neuro Oncol. 2024;26:1083-1096.
    PubMed         Abstract available
    
    
31. HASKELL-MENDOZA AP, Reason EH, Gonzalez AT, Jackson JD, et al
    Automated segmentation of ablated lesions using deep convolutional neural networks: A basis for response assessment following laser interstitial thermal therapy.
    Neuro Oncol. 2024;26:1152-1162.
    PubMed         Abstract available
    
    
32. GALBRAITH K, Garcia M, Wei S, Chen A, et al
    Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.
    Neuro Oncol. 2024;26:1042-1051.
    PubMed         Abstract available
    
    
33. NAYAK L, Bettegowda C, Scherer F, Galldiks N, et al
    Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review.
    Neuro Oncol. 2024;26:993-1011.
    PubMed         Abstract available
    
    
34. PARK YW, Jang G, Kim SB, Choi K, et al
    Leptomeningeal Metastases in IDH-wildtype Glioblastomas Revisited: Comprehensive Analysis of Incidence, Risk Factors, and Prognosis Based on Post-contrast FLAIR.
    Neuro Oncol. 2024 Jun 1:noae091. doi: 10.1093.
    PubMed         Abstract available
    
    
35. LITA A, Sjoberg J, Pacioianu D, Siminea N, et al
    Raman-based machine learning platform reveals unique metabolic differences between IDHmut and IDHwt glioma.
    Neuro Oncol. 2024 Jun 3:noae101. doi: 10.1093.
    PubMed         Abstract available
    
    
36. GROGAN PT, Vogelbaum MA
    Diffuse Midline (H3 K27M-Mutant) Glioma in Adults - Resection Fails to Matter.
    Neuro Oncol. 2024 Jun 3:noae099. doi: 10.1093.
    PubMed        
    
    
37. ROESLER J, Spitzer D, Jia X, Aasen SN, et al
    Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasis.
    Neuro Oncol. 2024 Jun 4:noae094. doi: 10.1093.
    PubMed         Abstract available
    
    
38. MYNAREK M, Rossius A, Guiard A, Ottensmeier H, et al
    Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa - Results of the HIT 2000 trial.
    Neuro Oncol. 2024 Jun 5:noae092. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neurology

39. HERZI D, Le Garff-Tavernier M, Sourdeau E, Choquet S, et al
    Prognostic Value of CSF IL-10 at Early Assessment of Induction Chemotherapy in Primary CNS Lymphomas: A LOC Network Study.
    Neurology. 2024;102:e209527.
    PubMed         Abstract available
    
    

    
    Neuroradiology

40. PONS-ESCODA A, Naval-Baudin P, Viveros M, Flores-Casaperalta S, et al
    DSC-PWI presurgical differentiation of grade 4 astrocytoma and glioblastoma in young adults: rCBV percentile analysis across enhancing and non-enhancing regions.
    Neuroradiology. 2024 Jun 5. doi: 10.1007/s00234-024-03385.
    PubMed         Abstract available
    
    

    
    Neurosurgery

41. MORETTO M, Luciani BF, Zigiotto L, Saviola F, et al
    Resting State Functional Networks in Gliomas: Validation With Direct Electric Stimulation of a New Tool for Planning Brain Resections.
    Neurosurgery. 2024 Jun 5. doi: 10.1227/neu.0000000000003012.
    PubMed         Abstract available
    
    
42. ZOHDY YM, Garzon-Muvdi T
    In Reply: Volumetric Analysis of Spheno-Orbital Meningiomas: Prognostic Correlation and a Compartmentalized Approach.
    Neurosurgery. 2024 Jun 7. doi: 10.1227/neu.0000000000003028.
    PubMed        
    
    
43. MARINIELLO G, Corvino S
    Letter: Volumetric Analysis of Spheno-Orbital Meningiomas: Prognostic Correlation and a Compartmentalized Approach.
    Neurosurgery. 2024 Jun 7. doi: 10.1227/neu.0000000000003027.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.